Ate-Bev Early Response Prediction Model in Advanced HCC — Stella

stellabeta Find trials matched to me Trial Match

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Ate-Bev Early Response Prediction Model in Advanced HCC — Stella

Recruiting

Back to Hepatocellular Carcinoma trials

Trial locations(1 site)

South Korea

Seoul National University Hospital, Seoul

Key details

Sponsor

Seoul National University Hospital

Enrollment target

~170 participants

Started

July 2022

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 80 Years

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov